Covaxin Supply
- All
- News
- Videos
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
- Thursday April 28, 2022
- India News | Press Trust of India
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
www.ndtv.com
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
- Thursday April 21, 2022
- India News | Reported by Ankita Mukherji, Edited by Anindita Sanyal
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
-
www.ndtv.com
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
- Monday April 4, 2022
- India News | Press Trust of India
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
www.ndtv.com
-
No Impact Of WHO Action On Covaxin, Have Not Supplied To Any UN Agency: Bharat Biotech
- Monday April 4, 2022
- India News | Press Trust of India
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
www.ndtv.com
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
- Sunday April 3, 2022
- India News | Reported by Vishnu Som, Edited by Debanish Achom
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
www.ndtv.com
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
- Saturday August 14, 2021
- India News | Press Trust of India
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
www.ndtv.com
-
75 Million Covaxin Doses Supplied, Says Bharat Biotech
- Friday August 13, 2021
- India News | Asian News International
Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
-
www.ndtv.com
-
"Quality Issues Behind Covaxin Shortage": Government Vaccine Panel Chief
- Monday August 2, 2021
- India News | Reported by Sreenivasan Jain, Edited by Deepshikha Ghosh
The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.
-
www.ndtv.com
-
Bharat Biotech Commits 500 Million Doses Of Covaxin To Centre
- Friday July 23, 2021
- India News | Press Trust of India
Bharat Biotech today said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
-
www.ndtv.com
-
Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates: Report
- Saturday July 17, 2021
- India News | Press Trust of India
The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources said.
-
www.ndtv.com
-
Punjab Running Out Of Vaccines, Calls For Increase In Supply From Centre
- Friday July 9, 2021
- India News | Press Trust of India
With Punjab running out of coronavirus vaccine Covishield and left with only one day's stock of Covaxin, Chief Minister Amarinder Singh today reiterated the need for enhanced supplies from the Centre, his office said.
-
www.ndtv.com
-
Bharat Biotech Says COVID-19 Vaccine Covaxin At Rs 150 Per Dose To Centre "Not Sustainable"
- Tuesday June 15, 2021
- India News | Press Trust of India
The supply price of Bharat Biotech's COVID-19 vaccine Covaxin to the central government at Rs 150 per dose is not sustainable in the long run, the vaccine maker said on Tuesday.
-
www.ndtv.com
-
Big Relief For Delhi As It Receives Major Supplies Of Covid Vaccine Doses
- Wednesday June 9, 2021
- India News | Reported by Sharad Sharma, Edited by Harish Pullanoor
The Delhi government has been at loggerheads with the Centre of supplies of Covid vaccines. Now the state has received over 1.2 lakh of Covishield and 20,000 additional doses of Covaxin.
-
www.ndtv.com
-
Assam Covaxin Shortage Grows Into Crisis, Some Miss Second Dose Deadline
- Monday June 7, 2021
- India News | Written by Ratnadip Choudhury
For the last five days, Baisistha Deka has been visiting the Hengrabari Medical Unit vaccine centre in Guwahati, the only permanent vaccine centre in the city that has access to Covaxin supplies, in the hope of getting his second dose.
-
www.ndtv.com
-
Assam Stops Administering Covaxin First Dose, Cites Short Supply
- Saturday June 5, 2021
- India News | Written by Ratnadip Choudhury, Edited by Saikat Kumar Bose
The Assam government has decided to stop administering the first dose of Covaxin due to short supply.
-
www.ndtv.com
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
- Thursday April 28, 2022
- India News | Press Trust of India
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
www.ndtv.com
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
- Thursday April 21, 2022
- India News | Reported by Ankita Mukherji, Edited by Anindita Sanyal
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
-
www.ndtv.com
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
- Monday April 4, 2022
- India News | Press Trust of India
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
www.ndtv.com
-
No Impact Of WHO Action On Covaxin, Have Not Supplied To Any UN Agency: Bharat Biotech
- Monday April 4, 2022
- India News | Press Trust of India
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
www.ndtv.com
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
- Sunday April 3, 2022
- India News | Reported by Vishnu Som, Edited by Debanish Achom
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
www.ndtv.com
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
- Saturday August 14, 2021
- India News | Press Trust of India
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
www.ndtv.com
-
75 Million Covaxin Doses Supplied, Says Bharat Biotech
- Friday August 13, 2021
- India News | Asian News International
Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
-
www.ndtv.com
-
"Quality Issues Behind Covaxin Shortage": Government Vaccine Panel Chief
- Monday August 2, 2021
- India News | Reported by Sreenivasan Jain, Edited by Deepshikha Ghosh
The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.
-
www.ndtv.com
-
Bharat Biotech Commits 500 Million Doses Of Covaxin To Centre
- Friday July 23, 2021
- India News | Press Trust of India
Bharat Biotech today said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
-
www.ndtv.com
-
Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates: Report
- Saturday July 17, 2021
- India News | Press Trust of India
The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources said.
-
www.ndtv.com
-
Punjab Running Out Of Vaccines, Calls For Increase In Supply From Centre
- Friday July 9, 2021
- India News | Press Trust of India
With Punjab running out of coronavirus vaccine Covishield and left with only one day's stock of Covaxin, Chief Minister Amarinder Singh today reiterated the need for enhanced supplies from the Centre, his office said.
-
www.ndtv.com
-
Bharat Biotech Says COVID-19 Vaccine Covaxin At Rs 150 Per Dose To Centre "Not Sustainable"
- Tuesday June 15, 2021
- India News | Press Trust of India
The supply price of Bharat Biotech's COVID-19 vaccine Covaxin to the central government at Rs 150 per dose is not sustainable in the long run, the vaccine maker said on Tuesday.
-
www.ndtv.com
-
Big Relief For Delhi As It Receives Major Supplies Of Covid Vaccine Doses
- Wednesday June 9, 2021
- India News | Reported by Sharad Sharma, Edited by Harish Pullanoor
The Delhi government has been at loggerheads with the Centre of supplies of Covid vaccines. Now the state has received over 1.2 lakh of Covishield and 20,000 additional doses of Covaxin.
-
www.ndtv.com
-
Assam Covaxin Shortage Grows Into Crisis, Some Miss Second Dose Deadline
- Monday June 7, 2021
- India News | Written by Ratnadip Choudhury
For the last five days, Baisistha Deka has been visiting the Hengrabari Medical Unit vaccine centre in Guwahati, the only permanent vaccine centre in the city that has access to Covaxin supplies, in the hope of getting his second dose.
-
www.ndtv.com
-
Assam Stops Administering Covaxin First Dose, Cites Short Supply
- Saturday June 5, 2021
- India News | Written by Ratnadip Choudhury, Edited by Saikat Kumar Bose
The Assam government has decided to stop administering the first dose of Covaxin due to short supply.
-
www.ndtv.com